Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery

PURPOSE: Angiotensin-converting enzyme inhibitors (ACEIs) are medications generally prescribed for patients with high cardiovascular risk; however, they are suboptimally used due to frequent adverse events (AEs). The present study aimed to identify and replicate the genetic variants associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chan Joo, Choi, Bogeum, Pak, Hayeon, Park, Jung Mi, Lee, Ji Hyun, Lee, Sang-Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965428/
https://www.ncbi.nlm.nih.gov/pubmed/35352885
http://dx.doi.org/10.3349/ymj.2022.63.4.342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965428/
https://www.ncbi.nlm.nih.gov/pubmed/35352885
http://dx.doi.org/10.3349/ymj.2022.63.4.342

Ejemplares similares